Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Adicet Bio, Inc. logo

Adicet Bio, Inc. (ACET) Stock Ticker

NASDAQ: ACET · Healthcare · Biotechnology
$9.02+9.07%
USD · as of 2026-09-27 · market cap $84.3M
Open ACET in TickrDownload for iPhone

ACET right now

Trading at the top of its 52-week range.
Options expect by Oct 6±17.3%
Options expect by Oct 29±35.8%
Priced in for Nov 4 earnings±39.2%
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full ACET picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on ACET
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Adicet Bio, Inc.

Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The company’s strategy involves engineering gamma delta T cells with chimeric antigen receptors (CARs) and T cell receptor-like antibodies. This advanced modification is designed to achieve more precise targeting of tumors, enhance the body's natural and acquired immune responses against cancer, and provide sustained therapeutic benefits for patients. ADI-001, its most advanced therapeutic candidate, is presently in a Phase I clinical trial for individuals with non-Hodgkin's lymphoma. Additionally, Adicet Bio is developing ADI-002, which is undergoing preclinical investigations for its potential in treating a range of solid tumors. The company is headquartered in Boston, Massachusetts.

ACET stock facts

Ticker symbolACET
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryBiotechnology
Market cap$84.3M
CEOChen Schor
Employees102
HeadquartersBoston, MA, US
IPO date2018-01-26
Websitewww.adicetbio.com

What you can see for ACET on Tickr

Live ACET price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ACET report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Adicet Bio, Inc.?

The ticker symbol for Adicet Bio, Inc. is ACET, listed on the NASDAQ Global Market.

What is ACET?

Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The company’s strategy involves engineering gamma delta T cells with chimeric antigen receptors (CARs) and T cell receptor-like antibodies. This advanced modification is designed to achieve more precise targeting of tumors, enhance the…

HomeExploreMarketLists
All pages